Autofleet Provides Vehicle-as-a-Service Platform for Keolis Autonomous Electric Shuttle Deployment in Sweden
18.3.2021 08:00:00 EET | Business Wire | Press release
Autofleet, a provider of AI-powered fleet optimization solutions, was selected by Keolis, a public transport operator, to provide its platform for an autonomous electric vehicle (AEV) project in Gothenburg, Sweden. Shuttle operation began on January 18, 2021 on behalf of local public transport authority Västtrafik. The autonomous shuttle service is the first project in an ongoing collaboration to utilize Autofleet’s platform for management of Keolis’ new mobility solutions.
The shuttle service, which is integrated into the city of Gothenburg’s public transportation network as line 56, will serve a route that covers industrial and residential sites using two autonomous electric shuttles manufactured by Navya. Designed to operate in conditions including sub-zero temperatures and snow, this autonomous electric shuttle service is the city’s most advanced mobility project to-date.
Autofleet’s platform aggregates and analyzes granular shuttle data through an integration with Navya’s API in real time to produce actionable insights for operators around the project’s performance. The interface tracks shuttles at the individual sensor level and continually provides data such as station and passenger usage, allowing Keolis to gain clear insights for optimization and improvement of the service. Automated notification and alerting capabilities keep the operational teams aware of field events as they occur. In addition, the Autofleet driver app allows safety operators to track and share reports with their team in a single interface.
Autofleet’s platform is agnostic to the vehicle manufacturer or vehicle type. For their continued work with Autofleet, Keolis is able to integrate autonomous shuttles and electric or internal combustion engine-powered vehicles into the platform, providing the transport operator with a single point of access for managing and scaling their deployments.
“Autofleet’s platform provides impactful data that allows us to measure KPIs, and in turn improve our toolkit of services for future projects,” said Scheherazade Zekri, Director of New Mobility Services at Keolis Group. “The company’s work with us is crucial for developing new autonomous shuttle services that better manage fleets and serve commuters.”
“Autofleet's goal is to implement sustainable mobility services and support the transition of asset heavy fleets to Vehicle as a Service providers.” said Kobi Eisenberg, CEO at Autofleet. “We are excited to partner with Keolis on this project in order to execute autonomous operations in extreme conditions serving the transportation needs of communities globally.”
Autofleet offers fleet owners and operators a platform to automate and optimize fleet management for organizations and has partnered with other global fleets and manufacturers including Avis Budget Group, Zipcar, Keolis and Suzuki. In April 2020, Autofleet announced a capital raise totaling $7.5 million from its Series A, led by MizMaa Ventures, and seed financing, led by Maniv Mobility.
About Autofleet
Autofleet provides the leading Vehicle-as-a-Service platform for fleets to optimize existing operations and to seamlessly launch new business models from existing assets. The platform leverages advanced machine-learning algorithms for demand prediction, optimized placement and matching, automated pit-stop management and in/de-fleeting, and more. For more information, please visit https://www.autofleet.io/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005879/en/
Contact information
Leo Traub
Antenna Group for Autofleet
autofleet@antennagroup.com
(646) 883-3562
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom